BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26397395)

  • 1. Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.
    Han XF; He X; Wang M; Xu D; Hao LP; Liang AH; Zhang J; Zhou ZM
    Eur J Med Chem; 2015 Oct; 103():473-87. PubMed ID: 26397395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
    Zhang J; Wang JL; Yu WF; Zhou ZM; Tao WC; Wang YC; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2013 Nov; 69():44-54. PubMed ID: 24007859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
    Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
    Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of AT
    Wu Z; Anh NTP; Yan YJ; Xia MB; Wang YH; Qiu Y; Chen ZL
    Eur J Med Chem; 2019 Nov; 181():111553. PubMed ID: 31369932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.
    Bai R; Wei Z; Liu J; Xie W; Yao H; Wu X; Jiang J; Wang Q; Xu J
    Bioorg Med Chem; 2012 Aug; 20(15):4661-7. PubMed ID: 22750010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
    Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
    J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities.
    Zhu W; Da Y; Wu D; Zheng H; Zhu L; Wang L; Yan Y; Chen Z
    Bioorg Med Chem; 2014 Apr; 22(7):2294-302. PubMed ID: 24613628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
    Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
    Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Phenyl indole derivatives as AT1 antagonists with anti-hypertension activities: Design, synthesis and biological evaluation.
    Zhu W; Bao X; Ren H; Da Y; Wu D; Li F; Yan Y; Wang L; Chen Z
    Eur J Med Chem; 2016 Jun; 115():161-78. PubMed ID: 27017546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist: a review.
    Vyas VK; Ghate M
    Mini Rev Med Chem; 2010 Dec; 10(14):1366-84. PubMed ID: 20937029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and antihypertensive activity of 2-phenyl substituted benzimidazoles.
    Khan MT; Razi MT; Jan SU; Mukhtiar M; Gul R; IzharUllah -; Hussain A; Hashmi AM; Ahmad MT; Shahwani NA; Rabbani I
    Pak J Pharm Sci; 2018 May; 31(3(Supplementary)):1067-1074. PubMed ID: 29731445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of a new angiotensin II receptor antagonist.
    Zheng HL; Zhu WB; Wu D; Da YJ; Yan YJ; Bian J; Chen ZL
    Drug Res (Stuttg); 2014 Dec; 64(12):656-62. PubMed ID: 24573978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies.
    Ojima M; Igata H; Tanaka M; Sakamoto H; Kuroita T; Kohara Y; Kubo K; Fuse H; Imura Y; Kusumoto K; Nagaya H
    J Pharmacol Exp Ther; 2011 Mar; 336(3):801-8. PubMed ID: 21123673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.
    Agelis G; Resvani A; Durdagi S; Spyridaki K; Tůmová T; Slaninová J; Giannopoulos P; Vlahakos D; Liapakis G; Mavromoustakos T; Matsoukas J
    Eur J Med Chem; 2012 Sep; 55():358-74. PubMed ID: 22889560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel fluoro-substituted benzimidazole derivatives with anti-hypertension activities.
    Wu Z; Xia MB; Bertsetseg D; Wang YH; Bao XL; Zhu WB; Tao-Xu ; Chen PR; Tang HS; Yan YJ; Chen ZL
    Bioorg Chem; 2020 Aug; 101():104042. PubMed ID: 32650179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
    Vyas VK; Gupta N; Ghate M; Patel S
    SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.
    Ries UJ; Mihm G; Narr B; Hasselbach KM; Wittneben H; Entzeroth M; van Meel JC; Wienen W; Hauel NH
    J Med Chem; 1993 Dec; 36(25):4040-51. PubMed ID: 8258826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of new fluorine substituted derivatives as angiotensin II receptor antagonists with anti-hypertension and anti-tumor effects.
    Da YJ; Yuan WD; Xin T; Nie YY; Ye Y; Yan YJ; Liang LS; Chen ZL
    Bioorg Med Chem; 2012 Dec; 20(24):7101-11. PubMed ID: 23122933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel potent angiotensin II receptor 1 antagonists.
    Bao X; Zhu W; Yuan W; Zhu X; Yan Y; Tang H; Chen Z
    Eur J Med Chem; 2016 Nov; 123():115-127. PubMed ID: 27474928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.